K223481 is an FDA 510(k) clearance for the VITEK® 2 Streptococcus Tetracycline (<=0.25 - >=16 µg/mL). This device is classified as a System, Test, Automated, Antimicrobial Susceptibility, Short Incubation (Class II - Special Controls, product code LON).
Submitted by bioMerieux, Inc. (Hazelwood, US). The FDA issued a Cleared decision on February 3, 2023, 77 days after receiving the submission on November 18, 2022.
This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.1645.